Estimate Recalculated Sep 9, 2024 12:42AM EST
Malin Life Sciences Holdings Ltd has an estimated net worth of $21.4 Million. This is based on reported shares across multiple companies, which include Poseida Therapeutics, Inc., and Novan, Inc..
Malin Life Sciences Holdings Ltd's CIK is 0001685138
2021 was Malin Life Sciences Holdings Ltd's most active year for acquiring shares with 12 total transactions. Malin Life Sciences Holdings Ltd's most active month to acquire stocks was the month of October. 2020 was Malin Life Sciences Holdings Ltd's most active year for disposing of shares, totalling 4 transactions. Malin Life Sciences Holdings Ltd's most active month to dispose stocks was the month of June. 2022 saw Malin Life Sciences Holdings Ltd paying a total of $7,525,000.00 for 2,150,000 shares, this is the most they've acquired in one year. In 2020 Malin Life Sciences Holdings Ltd cashed out on 11,457,593 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!